“When asked about new therapies, most neurologists wanted those that “Provide added years of life (maintaining quality of life), not months of life.”
Interesting I know of a promising new drug that might fit that bill….
https://alsnewstoday.com/news/neurologists-frustrated-with-als-treatments-now-on-market-study/
Amylyx class action Relyvrio, page-13
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.010(4.88%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 21.5¢ | $166.2K | 772.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6499 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 264679 | 3 |
View Market Depth
| Last trade - 11.08am 24/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |